BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 12450419)

  • 1. Matrix metalloproteinases in colorectal cancer.
    Mysliwiec AG; Ornstein DL
    Clin Colorectal Cancer; 2002 Feb; 1(4):208-19. PubMed ID: 12450419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
    Ichikawa Y; Ishikawa T; Tanaka K; Togo S; Shimada H
    Nihon Geka Gakkai Zasshi; 2001 May; 102(5):376-80. PubMed ID: 11393999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
    Groblewska M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer.
    Surlin V; Ioana M; Pleşea IE
    Rom J Morphol Embryol; 2011; 52(1 Suppl):231-6. PubMed ID: 21424059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
    Wan Y; Wei Q; Pan Y; Liu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):510-3. PubMed ID: 11832095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
    Okada Y
    Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
    Leeman MF; Curran S; Murray GI
    J Pathol; 2003 Dec; 201(4):528-34. PubMed ID: 14648655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA; Bergin FG; Leaper DJ
    Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The other side of MMPs: protective roles in tumor progression.
    Martin MD; Matrisian LM
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S; Murray GI
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer: targeting metastasis and angiogenesis.
    Chu E
    Clin Colorectal Cancer; 2002 Feb; 1(4):200. PubMed ID: 12450417
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
    Zhang D; Samani AA; Brodt P
    Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis.
    Soreide K; Janssen EA; Körner H; Baak JP
    J Pathol; 2006 Jun; 209(2):147-56. PubMed ID: 16691544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
    Brabletz T; Jung A; Dag S; Reu S; Kirchner T
    Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
    Łukaszewicz M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.